Search Results - "Dellanna, F"

Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes by Thomas, A., Solymos, E., Schänzer, W., Baume, N., Saugy, M., Dellanna, F., Thevis, M.

“…[Display omitted] ► Antidiuretic-hormones Vasopressin and Desmopressin have a relevancy in doping controls. ► Determination in urinary specimens by mass…”
Get full text

Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study by Dellanna, F, Winkler, R E, Bozkurt, F, Schettler, V, Graf, S, Bockreiss, N, Fliser, D

“…To analyse the impact of dosing decisions for continuous erythropoietin receptor activator (C.E.R.A.), a continuous erythropoietin receptor activator. This was…”
Get more information

Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study by Fliser, D., Kleophas, W., Dellanna, F., Winkler, R.E., Backs, W., Kraatz, U., Fassbinder, W., Wizemann, V., Strack, G.

“…Abstract Background and objectives: C.E.R.A., a continuous erythropoietin receptor activator, offers once-monthly dosing without compromising haemoglobin…”
Get full text

The PRIMAVERA study protocol design: Evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease by Fliser, D, Dellanna, F, Koch, M, Seufert, J, Witzke, O, Hauser, I.A

“…Abstract Erythropoiesis stimulating agents (ESA) are widely used for hemoglobin correction in patients suffering from renal anemia. However, their beneficial…”
Get full text

Internal filtration-advantage in haemodialysis ? by DELLANNA, F, WUEPPER, A, BALDAMUS, C. A

“…Internal filtration is defined as the total water flux across the membrane within the closed blood and dialysate compartment of a dialyser. The aim of our…”
Get full text

Efficacy of cinacalcet administered with the first meal after dialysis: the SENSOR Study by Schaefer, R M, Bover, J, Dellanna, F, Sanz, D, Asensio, C, Sánchez González, M C, Gross, P, Zani, V, Carter, D, Jehle, P M

“…Cinacalcet, a novel calcimimetic, simultaneously lowers parathyroid hormone (PTH), phosphorus (P), calcium (Ca) and Ca x P in patients who are on dialysis with…”
Get more information

Interdisciplinary interaction in vascular diseases of the eye, diabetes and diabetic retinopathy by Kleophas, W, Dellanna, F

“…The incidence of diabetes mellitus type 2 is greatly increasing worldwide. An early therapy with intensified control of diabetes and blood pressure is…”
Get full text

Local transport processes in high-flux hollow fiber dialyzers by Wüpper, A., Dellanna, F., Baldamus, C.A., Woermann, D.

“…A method is described and tested experimentally to determine the profile of the radial volume flow density, the concentration profiles of an impermeable and…”
Get full text

Retrofiltration rates in high-flux hollow fiber hemodialyzers: analysis of clinical data by Wüpper, A., Woermann, D., Dellanna, F., Baldamus, C.A.

“…Clinical data obtained with high-flux hollow fiber hemodialyzers operating under the condition of zero net volume flow of filtrate are analyzed theoretically…”
Get full text

The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study by Locatelli, Francesco, Spasovski, Goce, Dimkovic, Nada, Wanner, Christoph, Dellanna, Frank, Pontoriero, Giuseppe

“…Background This study compared the effects of short-term titrated colestilan (a novel non-absorbable, non-calcium, phosphate binder) with placebo, and…”
Get full text

HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience by Dellanna, Frank, Goldsmith, David, Krendyukov, Andriy, Seidl, Andreas, Höbel, Nadja, Combe, Christian

“…Erythropoiesis-stimulating agents, such as recombinant human erythropoietin, are commonly used for the treatment of anemia in patients with chronic kidney…”
Get full text

Tolérance du roxadustat par rapport aux agents stimulant l’érythropoïèse dans le traitement de l’anémie chez les patients atteints de maladie rénale chronique non dialysés ou incidents en dialyse : analyse groupée de quatre études de phase 3 by Barratt, J., Dellanna, F., Portoles, J., Choukroun, G., de Nicola, L., Reusch, M., Young, J., Dimković, N.

Get full text

Bilan martial des patients traités par roxadustat pour anémie liée à leur maladie rénale chronique : analyse post hoc chez les patients non dialysés ou incidents en dialyse inclus dans quatre études de phase 3 by Barratt, J., Dellanna, F., Portoles, J., Choukroun, G., De Nicola, L., Reusch, M., Young, J., Jiletcovici, A., Dimković, N.

Get full text

Anaemia in CKD 5D by Mikhail, A., Kaplan, M., Macdougall, I., Schmidt, R. J., Rastogi, A., Wang, W., Tong, S., Mayo, M., Oestreicher, N., Schiller, B., Green, J. M., Verma, R., Leu, K., Mortensen, R. B., Young, P. R., Schatz, P., Wojchowski, D. M., Shimonaka, Y., Sasaki, Y., Yorozu, K., Sasaki, M. N., Ikuta, K., Kohgo, Y., Omori, Y. M., Hiramatsu, M., Momoki, N., Kakio, Y., Shibuto, N., Takeuchi, H., Fukumoto, M., Maruyama, K., Matsuo, Y., Omori, Y., Robinson, B. M., Larkina, M., Goodkin, D. A., Li, Y., Locatelli, F., Nolen, J., Kleophas, W., Pisoni, R. L., Sibbel, S., Brunelli, S., Krishnan, M., Horie, M., Hasegawa, E., Minoshima, K.-i., Ambrus, C., Kerkovits, L., Szegedi, J., Benke, A., Toth, E., Nagy, L., Borbas, B., Rozinka, A., Nemeth, J., Varga, G., Kulcsar, I., Gergely, L., Szakony, S., Kiss, I., Danielson, K., Qureshi, A. R., Heimburger, O., Stenvinkel, P., Lindholm, B., Hylander-Rossner, B., Germanis, G., Hansson, M., Beshara, S., Barany, P., Dueymes, J.-M., Kolko, A., Couchoud, C., Combe, C., Covic, A., Goldsmith, D., Zaoui, P., Gesualdo, L., London, G., Dellanna, F., Mann, J., Turner, M., Muenzberg, M., MacDonald, K., Denhaerynck, K., Abraham, I., Sanchez, M. B., Casero, R. C., Ortiz, R. V., Carmelo, I. G., Munoz, S. C., Gomez, E. R., Rodriguez, C. S., Kuji, T., Fujikawa, T., Kakimoto-Shino, M., Shibata, K., Toya, Y., Umemura, S.

Get full text

Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients by Weinreich, Thomas, Leistikow, Frank, Hartmann, Hagen-Georg, Vollgraf, Günter, Dellanna, Frank

“…Once‐monthly administration of CERA, a continuous erythropoietin receptor activator, has shown equivalent efficacy to shorter‐acting erythropoiesis‐stimulating…”
Get full text

Bestimmung der glomerulären Filtrationsrate bei chronischer Niereninsuffizienz: Voraussetzung zur Risiko- und Progressionsabschätzung sowie zu weiterer Diagnostik und Therapie by Dellanna, F.

“…Zusammenfassung Die Näherungsformeln, insbesondere die CKD-EPI- und MDRD-Formel, stellen eine wichtige Bereicherung in der Diagnostik der Nierenfunktion dar,…”
Get full text

Interdisziplinäre Interaktion bei vaskulärer Erkrankung des Auges, Diabetes und diabetischer Retinopathie by Kleophas, W., Dellanna, F.

“…Zusammenfassung Diabetes mellitus Typ II ist eine weltweit stark zunehmende Erkrankung. Einer frühzeitigen Therapie mit intensivierter Diabetes- und…”
Get full text

Interdisciplinary interaction in vascular diseases of the eye, diabetes and diabetic retinopathy by Kleophas, W, Dellanna, F

Get full text

Rechtsseitiger Gesichtstumor bei einem 39-jährigen Hämodialysepatienten by Kleophas, W., Hetzel, G.R., Dellanna, F., Kösters, W., Westhoff, A.

Get full text

Differential diagnosis of initial manifestations of systemic lupus erythematosus by Schwick, N, Schmitz, S, Dellanna, F, Neveling, M, Gheorghiu, T

Get more information